MKI67 and breast cancer: Using sera from patients with breast cancer categorized on the basis of HR status and the level of the Ki67 proliferation marker, they investigated the concentration of EPA and DHA in HDL and non-HDL, which are the two groups of circulating lipoproteins used in clinical and epidemiological studies.